Treatment effects of Elexacaftor/Tezacaftor/Ivacaftor in people with CF carrying non-F508del mutations

Autor: Livnat, Galit, Dagan, Adi, Heching, Moshe, Shmueli, Einat, Prais, Dario, Yaacoby-Bianu, Karin, Stein, Nili, Mei-Zahav, Meir, Gur, Michal, Cohen-Cymberknoh, Malena, Shteinberg, Michal
Zdroj: In Journal of Cystic Fibrosis May 2023 22(3):450-455
Databáze: ScienceDirect